key: cord-0869105-oxcv88w9 authors: Vlachopoulos, Charalambos; Terentes-Printzios, Dimitrios; Katsaounou, Paraskevi; Solomou, Eirini; Gardikioti, Vasiliki; Exarchos, Dimitrios; Economou, Dimitrios; Christopoulou, Georgia; Kalkinis, Antonios-Dimosthenis; Kafouris, Pavlos; Antonopoulos, Alexios; Lazaros, Georgios; Kotanidou, Anastasia; Datseris, Ioannis; Tsioufis, Konstantinos; Anagnostopoulos, Constantinos title: Time-related aortic inflammatory response, as assessed with (18)F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study date: 2022-05-02 journal: J Nucl Cardiol DOI: 10.1007/s12350-022-02962-1 sha: b333df7ea621f9ca597f4d037af263149c1a9314 doc_id: 869105 cord_uid: oxcv88w9 AIM: Arterial involvement has been implicated in the coronavirus disease of 2019 (COVID-19). Fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) imaging is a valuable tool for the assessment of aortic inflammation and is a predictor of outcome. We sought to prospectively assess the presence of aortic inflammation and its time-dependent trend in patients with COVID-19. METHODS: Between November 2020 and May 2021, in this pilot, case-control study, we recruited 20 patients with severe or critical COVID-19 (mean age of 59 ± 12 years), while 10 age and sex-matched individuals served as the control group. Aortic inflammation was assessed by measuring (18)F-FDG uptake in PET/CT performed 20-120 days post-admission. Global aortic target to background ratio (GLA-TBR) was calculated as the sum of TBRs of ascending and descending aorta, aortic arch, and abdominal aorta divided by 4. Index aortic segment TBR (IAS-TBR) was designated as the aortic segment with the highest TBR. RESULTS: There was no significant difference in aortic (18)F-FDG PET/CT uptake between patients and controls (GLA-TBR: 1.46 [1.40-1.57] vs. 1.43 [1.32-1.70], respectively, P = 0.422 and IAS-TBR: 1.60 [1.50-1.67] vs. 1.50 [1.42-1.61], respectively, P = 0.155). There was a moderate correlation between aortic TBR values (both GLA and IAS) and time distance from admission to (18)F-FDG PET-CT scan (Spearman’s rho = − 0.528, P = 0.017 and Spearman’s rho = − 0.480, p = 0.032, respectively). Patients who were scanned less than or equal to 60 days from admission (n = 11) had significantly higher GLA-TBR values compared to patients that were examined more than 60 days post-admission (GLA-TBR: 1.53 [1.42-1.60] vs. 1.40 [1.33-1.45], respectively, P = 0.016 and IAS-TBR: 1.64 [1.51-1.74] vs. 1.52 [1.46-1.60], respectively, P = 0.038). There was a significant difference in IAS- TBR between patients scanned ≤ 60 days and controls (1.64 [1.51-1.74] vs. 1.50 [1.41-1.61], P = 0.036). CONCLUSION: This is the first study suggesting that aortic inflammation, as assessed by (18)F-FDG PET/CT imaging, is increased in the early post COVID phase in patients with severe or critical COVID-19 and largely resolves over time. Our findings may have important implications for the understanding of the course of the disease and for improving our preventive and therapeutic strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-022-02962-1. The coronavirus disease of 2019 (COVID- 19) , caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the result of disruption of the immune, renin-angiotensin-aldosterone (RAA), and thrombotic balance. 1 All these mechanisms converge on vascular dysfunction as a common pathway. The main organs involved in COVID-19, i.e., the lungs, the heart, and the kidneys, exhibit similar findings of endothelial dysfunction and vasculitis with monoclonal cells, lymphocyte infiltration and intravascular thrombosis. 2 Transient increase of arterial stiffness that is associated with hospital stay length 3 attests to the vascular involvement in COVID-19. Nevertheless, the patients that end up with irreversible myocardial damage at longterm follow constitute a small percentage. 1, 4, 5 18-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) imaging is a valuable tool for the diagnosis and assessment of disease severity in different types of vascular and cardiac inflammation and infection [6] [7] [8] [9] and is a potential predictor of outcomes in different settings. 7,10, 11 We have shown that aortic FDG uptake is associated with disease severity and response to treatment in patients with lymphoma and hypercholesterolemia. 12, 13 There are very few observational studies regarding 18 F-FDG PET/CT in COVID-19 affected patients focusing on the lung FDG uptake. 14, 15 We investigated the effects of COVID-19 on a vascular level, by assessing 18 F-FDG PET/CT uptake in the aorta in patients with severe or critical illness. Between November 2020 and May 2021, we recruited 20 patients from two dedicated COVID 19 hospitalization centers (General Hospital 'Evaggelismos' and Thoracic Diseases General Hospital 'Sotiria' in Athens, Greece), who were diagnosed and admitted with severe or critical COVID 19. The criteria for severe COVID 19 were (1) SpO 2 \ 94% on room air at sea level, (2) and a respiratory rate [ 30 breaths/min, (3) PaO 2 /FiO 2 \ 300 mmHg or lung infiltrates [ 50%. The criteria for critical COVID 19 were the presence of respiratory failure, septic shock, and/or multiple organ dysfunction. 16 18 F-FDG PET/CT imaging between 20 to 120 days after hospital admission. Ten age and sex-matched individuals scheduled for 18 F-FDG PET/CT imaging served as the control group. They had a prior history of malignancy but were free of active disease at the time of the 18 F-FDG-PET/ CT investigation. Image acquisition was obtained following recommended protocols and as previously described. 9, 17 Patients were classified according to their cardiovascular risk as low, intermediate, high and very high risk for cardiovascular disease as suggested by the European Society Guidelines on prevention of cardiovascular disease. 18 Patients enrolled in the study had capacity to give informed consent ether at the time of admission, or they were enrolled in the study at the time that they were able to give informed consent. No surrogates were recruited to provide consent for the participants. The study was approved by the Institutional Research Ethics Committee and conducted according to institutional guidelines and the Declaration of Helsinki. The study was approved by the Institutional Research Ethics Committee and conducted according to institutional guidelines and the Declaration of Helsinki. The primary endpoints of the study were: (1) the difference of aortic inflammation as assessed by 18 F-FDG PET/CT between patients with recent COVID 19 and control subjects and (2) the association of aortic FDG uptake with time after admission in order to investigate the behavior of aortic inflammation over time post COVID 19. The secondary outcome was to investigate the association between aortic FDG uptake and disease severity biomarkers. In a post hoc analysis, we compared aortic FDG uptake in patients in early (B 60 days from admission) or late ([ 60 days from admission) recovery phase vs. aortic FDG uptake in control subjects. Image acquisition was obtained following recommended protocols and as previously described. None of the patients had blood glucose levels [ 200 mg dL -1 before injection. FDG was injected intravenously (3-4 MBq/kg) and scanning was performed at 60-120 minutes post-injection for aortic tracer uptake assessment. A low dose CT scan in a supine position was obtained for attenuation correction and image fusion. No CT intravenous (IV) contrast was administered. PET data were reconstructed using an ordered subset expectation maximization iterative reconstruction algorithm. Regions of interest (ROI) around the aortic wall were manually drawn along the entire aorta in consecutive axial slices at intervals of 5 mm. Metabolic activity within each arterial ROI was measured by maximum standardized uptake value (SUV max ). Six consecutive circular ROIs of 3 mm diameter, were drawn within the superior vena cava and an average venous SUV mean value was calculated. The arterial target to background ratio (TBR) was then derived by dividing the mean aortic SUV max to the average value of venous SUV mean . Finally, global aortic TBR (GLA-TBR) was calculated as the sum of TBRs of ascending and descending aorta, aortic arch, and abdominal aorta divided by 4. Index aortic segment TBR (IAS-TBR) was designated as the aortic segment with the highest TBR. Blood samples from the 20 COVID-19 patients were obtained \ 48 hours after admission. On each blood sample, high sensitivity troponin I (hs-Troponin I) and CRP (hs-CRP) were measured in the serum. hsCRP and hs-Troponin I were promptly available from the laboratory results of the 2 hospitals. Quantitative data are presented as mean values ± standard deviation (SD) or medians (interquartile range), while qualitative variables as absolute and relative frequencies. Parameters which exhibited a non-normally distribution were presented as the median (25th-75th percentile). For between-groups comparisons, the Student's ttest or v 2 test for continuous and categorical variables, respectively, were employed. For comparison of TBR values, Mann Whitney U test was performed. To assess the relation between aortic TBR and inflammatory markers, time distance since admission D-dimers and oxygen saturation (SO 2 ), Spearman's rho was employed. Linear regression analysis was performed using aortic TBR as the dependent variable and time distance from admission, age, sex and systematic inflammation as described by hs-CRP as covariates. 19 Further linear regression analysis was performed using aortic TBR as the dependent variable and time distance from admission, age, sex and CVD risk according to European Society of Cardiology (ESC) guidelines as covariates (Supplementary material). A two-tailed P-value \ 0.05 was considered significant. All statistical analyses were performed with the SPSS 20.0 (SPSS Inc., Chicago, IL, USA). Mean age of patients was 59 ± 12 years and 10 were males (60%). Ten patients had hypertension (50%), six had dyslipidemia (30%) and 6 were diabetics (30%). There were 6 smokers (60%) in the patient group. Six patients were on statins, six on angiotensin receptor blockers (ARBs) and one on aspirin (Table 1) . There was a moderate association between aortic TBR values (both GLA and IAS) and time distance from admission to 18 F-FDG PET-CT scan (Spearman's rho = -0.528, P = 0.017 and Spearman's rho = -0.480, P = 0.032, respectively) ( Figure 1 ). Multivariate analysis showed that both GLA and IAS-TBR remained moderately associated with time distance from admission to 18 F-FDG PET/CT and with systemic inflammation assessed by hs-CRP, even after adjustment for sex and age (Tables 2 and 3) . A multivariate analysis associating GLA and IAS-TBR with time distance from COVID 19 admission, using cardiovascular risk, age and sex as confounders is presented in the Supplement Tables 1 and 2, respectively. There was no significant difference in aortic 18 The median (interquartile range) time from admission to the 18 F-FDG PET/CT was 58.5 (45-74) days. Patients who were scanned less than or equal to 60 days from admission (n = 11) had significantly higher GLA-TBR values compared to patients that were examined more than 60 days post-admission (GLA-TBR B60 days = (Figure 2) . Out of all patients, 65% (n = 13) had critical COVID 19 and required ICU admission. There was no significant difference in aortic TBR between patients admitted to ICU and patients with severe COVID disease not requiring ICU admission (global Regarding localization of the index aortic segment in patients, higher FDG uptake values were observed more frequently in thoracic aorta (n = 14, 70%) compared to abdominal aorta (n = 6, 30%). Regarding circulating biomarkers, there was a modest association between both global aortic TBR and index vessel TBR and CRP (Spearman's rho = 0.662, P = 0.004 and Spearman's rho = 0.559, P = 0.020, respectively). There was no association between neither global nor index vessel aortic FDG uptake and troponin or d-dimer levels ( Table 4) . To the best of our knowledge, this is the first study that investigates prospectively the presence of aortic inflammation during early recovery in COVID-19 in severely or critically ill patients, as assessed by aortic 18 F-FDG PET/CT uptake. More specifically, our findings suggest that patients scanned earlier than 60 days post COVID-19 admission, demonstrate higher aortic inflammation compared to either patients scanned later or to control subjects. The time pattern of this aortic involvement shows a largely transient involvement. Furthermore, aortic TBR values are associated with higher CRP levels during admission. There is limited information on aortic FDG uptake in patients post COVID 19. 11, 12 Solini et al 12 showed in 10 patients that although patients and control subjects had similar vascular scores, as assessed by a semiquantitative method, there were higher aortic TBR scores in specific aortic regions in patients (thoracic aorta, right iliac artery, femoral arteries). A retrospective analysis of 18 Our results may have important clinical implications. 18 F-FDG PET/CT is a valuable tool for assessment of inflammation in the aorta in conditions where inflammation is present, such as malignancies and hyperlipidaemia 7,10,13 and can be used as an additional parameter for the evaluation of arterial atherosclerotic activity, 22 as well as large vessel vasculitis. 23 Furthermore, it can be used in the monitoring of disease since relapse was more common in patients with vasculitis when there was high aortic 18 F-FDG uptake during clinical remission. 24 Vascular involvement in patients with COVID-19 is common and even vaccination against SARS-CoV-2 has been associated with transient endothelial dysfunction. 25 Accordingly, the findings of this study could expand to identify patients at risk both the early and late post COVID-19 period. The cytokine storm induced by SARS-CoV-2 results in lung injury and multi-organ failure. 26 COVID-19-induced vasculitis can cause thrombosis (arterial or venous), as well as coronary or aortic dissection. 1 Histopathological postmortem findings in COVID-19 patients have shown increased inflammatory burden in patients with a severe clinical presentation and signs of endotheliitis in various affected organs. 2, 27 Importantly, a considerable percentage of patients develop long-standing COVID-19 symptoms often in the absence of elevated traditional inflammatory markers. 1, 5, 6 Interestingly, this condition is mainly associated to endothelial dysfunction 28 and some of these patients exhibit residual aortic inflammation, 20 Accordingly, assessment of aortic inflammation with 18 F-FDG PET/CT could predict, or serve as a marker of, longstanding COVID-19 mandating closer follow up and offering access to potentially available treatments. Our study is limited by its observational nature. No individual patient serial measurements with subsequent 18 F-FDG PET/CT scans were taken and this hypothesisgenerating study cannot prove causality. A further limitation is the relatively small number of patients. Practical shortcomings in the COVID-19 setting due to strict staff, and patient safety protocols, necessary to prevent spreading of disease, as well as enrolment of COVID-19 patients to numerous other interventional research protocols, led to a very cumbersome and challenging recruitment process that could explain the relatively small number of participants. Nevertheless, our study attests to the potential of this diagnostic modality to become clinically useful, when practical issues are addressed. Our findings are provided by cross-sectional and not individual prospective data. While they overall suggest a time-related recovery of inflammation, factors of resolution and the exact time pattern still remain unknown. Further research is needed to disentangle the process of recovery of inflammation (aortic and systemic) in patients with COVID-19. In conclusion, this is the first study suggesting by means of 18 F-FDG PET/CT imaging that patients may demonstrate high aortic inflammation early post COVID-19; however, this aortic involvement is largely transient. 18 F-FDG PET/CT imaging could recognise early patients that have residual aortic inflammation and may serve as a predictor of outcome both in the early and late post infection period. Larger prospective studies are needed to support this. In addition, our results could instigate investigation of even earlier phases of the disease. There is no conflict of interest. There was no funding for this study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Potential effects of coronaviruses on the cardiovascular system: A review Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 Arterial stiffness and COVID-19: A bidirectional cause-effect relationship Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease An update on the role of 18 F-FDG-PET/CT in major infectious and inflammatory diseases Role of PET/CT in the evaluation of aortic disease F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events 18 F-FDG uptake as a predictive factor for progressive aortic enlargement in aortic dissection Lymphoma severity and type are associated with aortic FDG uptake by 18 F-FDG PET/CT imaging original research Long-term administration of proprotein convertase subtilisin/kexin type 9 inhibitors reduces arterial FDG uptake et al 18 FDG-PET/CT findings in COVID-19: a single centre retrospective radiological review Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study COVID-19) Treatment Guidelines. National Institutes of Health Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) User's guide to correlation coefficients Aortic 18 F-FDG PET/CT hypermetabolism in patients with long COVID: A retrospective study FDG-PET/CT images of COVID-19: A comprehensive review The role of 18 FDG PET/CT imaging of aortic atherosclerosis: Prospective study and technique optimization Management of large-vessel vasculitis with FDG-PET: A systematic literature review and meta-analysis et al 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness Cytokine storm induced by SARS-CoV-2 Endothelial cell infection and endotheliitis in COVID-19 COVID 19 syndrome: Is it related to microcirculation and endothelial dysfunction, insights from TUN-EndCOV study. Front Cardiovasc Med 2021 Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Informed consent was obtained from all individual participants included in the study.